First, Do No Harm: Understanding Primary Care Providers' Perception of Risks Associated With Discussing Weight With

Katie A Loth1, Jocelyn Lebow2, Marc James Abrigo Uy1

  • 1University of Minnesota Medical School, Minneapolis, MN, USA.

Global Pediatric Health
|September 13, 2021
PubMed

Insights

Pediatric providers worry discussing weight with children may cause harm. They continue weight discussions carefully, aiming to reduce potential negative impacts on pediatric patients.

Area of Science:

  • Pediatrics
  • Health Behavior
  • Clinical Practice

Background:

  • Healthcare providers face challenges discussing weight with pediatric patients.
  • Concerns exist regarding potential negative impacts of weight conversations in children.

Purpose of the Study:

  • To explore primary care providers' perceptions of risks associated with discussing weight with pediatric patients.
  • To understand providers' commitment to best practices in pediatric weight management.
  • To identify strategies used by providers to mitigate perceived risks during weight discussions.

Main Methods:

  • Qualitative study utilizing one-on-one interviews.
  • Involved 20 primary care providers.
  • Focused on perceptions, adherence to best practices, and risk mitigation strategies.

Main Results:

  • Providers expressed concern about unintended negative consequences of discussing weight with children.
  • Despite concerns, providers continued routine BMI screening and weight-focused conversations.
  • Providers employed careful language and approaches to mitigate perceived risks.

Conclusions:

  • Pediatric primary care providers perceive potential negative outcomes from weight-related discussions.
  • Further research is needed to determine if weight-focused conversations should be avoided or if effective risk mitigation strategies exist.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
25
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
44
Ethical Standards II01:23

Ethical Standards II

Ethical standards are the backbone of nursing practice, guiding nurses as they interact with patients, families, and colleagues. These standards are crucial for providing safe, empathetic care centered on the patient's needs.
Nurses are entrusted with upholding various ethical principles and standards. Nurses forge solid therapeutic relationships using trust, empathy, autonomy, confidentiality, and professional competence.
Confidentiality is crucial, embodying respect for individual privacy...
926
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
25
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
204
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
34